Pharmacaribe LLC

PharmaCaribe develops and commercializes novel pharmaceutical and medical device solutions with streamlined regulatory pathways for rapid market entry. The company specializes in hypertonic saline inhalation solutions, including flagship products PulmoSal and NebuSal, formulated to USP standards with FDA-cleared (pH+) Bio-Balanced™ formulations. These solutions are designed for respiratory applications, including cystic fibrosis management and potential prophylactic/therapeutic applications for viral respiratory infections. The company combines clinical research with abbreviated development timelines to bring evidence-based respiratory therapeutics to market.